The aforementioned conditions, as well as COVID‐19, may result in over secretion of IL‐6 that can bind to IL‐6 receptors leading to activation of vascular endothelial growth factor and decreased expression of E‐cadherin, promoting vascular permeability, shock, and MOD [76]. This evidence concerns the gene IL6 and COVID-19.